Physician profile
David H Miller
NPI 1073617304
$2,809.21
in general payments reported to CMS, 2019-2025
13 companies · $867 in 2025
The $867 reported for 2025 was more than what 89% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $380 · 2020: $71.86 · 2021: $148 · 2022: $238 · 2023: $365 · 2024: $740 · 2025: $867.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,972.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,971.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $576.93 | 2019-2025 | Tryptyr, Precision7, Precision 1 |
| Johnson & Johnson Vision Care, INC. | $407.28 | 2019-2025 | Acuvue |
| Lkc Technologies, INC. | $270.56 | 2023-2024 | |
| Bausch & Lomb Americas INC. | $258.09 | 2024-2025 | Miebo, Xiidra, Infuse |
| Tarsus Pharmaceuticals, INC. | $243.65 | 2024-2025 | Xdemvy |
| Allergan, INC. | $239.88 | 2019-2022 | |
| Coopervision INC. | $149.71 | 2020-2024 | Clariti Contact Lens |
| Glaukos Corporation | $137.56 | 2023 | |
| Sun Pharmaceutical Industries INC. | $121.82 | 2025 | |
| Dompe US, INC. | $121.82 | 2025 | Oxervate |
| Mallinckrodt Hospital Products INC. | $121.82 | 2023 | Acthar |
| Novartis Pharmaceuticals Corporation | $101.02 | 2019 | |
| Horizon Therapeutics Plc | $59.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.